Prediction of sarcopenia using a combination of multiple serum biomarkers

Sarcopenia is a gradual loss of skeletal muscle mass and function with aging. Given that sarcopenia has been recognized as a disease entity, effective molecular biomarkers for early diagnosis are required. We recruited 46 normal subjects and 50 patients with moderate sarcopenia aged 60 years and old...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Ju Yeon, Hwang, Hyeoncheol, Kim, Seon-Kyu, Choi, Jeong Yi, Lee, Seung-Min, Bang, Hyun, Kwon, Eun-Soo, Lee, Kwang-Pyo, Chung, Sun Gun, Kwon, Ki-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988732/
https://www.ncbi.nlm.nih.gov/pubmed/29872072
http://dx.doi.org/10.1038/s41598-018-26617-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988732/
https://www.ncbi.nlm.nih.gov/pubmed/29872072
http://dx.doi.org/10.1038/s41598-018-26617-9

Ejemplares similares